The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

Aggressive lifestyle and risk factor control after ablation significantly lowers atrial fibrillation recurrence and improves ...

Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy ...

In the quest for more targeted lung cancer treatments, a researcher at the University of Missouri thinks the solution may lie in tiny bubble-shaped packages that cells use to talk to each other.

After a progression-free survival win last year raised hopes for the combo's potential in hepatocellular carcinoma, an overall survival miss brings the study to a close.

During a live event, Lori Wirth, MD, discussed next steps for treating a patient with progressive, radioactive ...

Chinese researchers have revealed a mechanism that triggers metastasis of hepatocellular carcinoma through the production of ...

Chinese researchers have revealed a mechanism that triggers metastasis of hepatocellular carcinoma (HCC)—the most common type ...

Discover Delcath’s innovative liver-targeted chemotherapy system and latest clinical data driving potential market expansion.